CD Private Equity Fund III Accelerates Capital Return with Early Sale at 1.7x MOIC
CD Private Equity Fund III (ASX:CD3) has secured an early liquidity event by selling an underlying investment at a 1.7x multiple of invested capital, positioning itself to distribute proceeds to unitholders in Q3 2026.
- Early exit from 2017 vintage fund at 82% of Q1 2026 NAV
- Transaction yields 1.7x net MOIC and 12.5% net IRR
- Cash proceeds of approximately US$5.6 million received with no fees
- Distribution to unitholders expected in Q3 2026
- Manager exploring further liquidity options in the portfolio
Early Sale Delivers Strong Returns Ahead of Schedule
K2 Asset Management, the responsible entity for CD Private Equity Fund III (ASX:CD3), has completed an early sale of an underlying fund investment, accelerating capital return to investors. The transaction involved U.S. Select Private Opportunities Fund III, LP (LP3), in which CD3 holds a 71.22% stake.
The secondary sale closed in early July 2026 at approximately 82% of the underlying fund’s Q1 2026 net asset value. LP3 received cash proceeds of around US$5.6 million with no deferred settlement terms or transaction fees, a clean exit that enhances the net return profile.
Solid Financial Metrics Highlight Investment Performance
This realisation delivers a final outcome of approximately 1.7 times net multiple on invested capital (MOIC) and a 12.5% net internal rate of return (IRR), metrics that underscore the strength of this vintage 2017 fund investment despite a challenging market backdrop.
The early liquidity event not only provides cash flow but also shortens the expected realisation timeline, offering unitholders a tangible return ahead of schedule. This comes after CD3 faced foreign exchange headwinds and fair value declines earlier in the year, which had pressured net asset values and earnings 71.2% interest in US Select Private Opportunities Fund III LP.
Distribution Plans and Portfolio Liquidity Strategy
The responsible entity expects to distribute proceeds to unitholders as soon as possible in Q3 2026, contingent on receipt of funds from LP3 and aligned with the Fund’s regular six-monthly distribution review process. This timing will be closely watched by investors eager for liquidity following recent volatility.
Meanwhile, the Manager remains active in assessing additional liquidity opportunities across the remaining portfolio holdings, seeking to balance timely capital returns with maximising value for investors.
Bottom Line?
CD3’s early exit at a healthy multiple signals potential for further liquidity events, but investors should watch for timing and quantum of upcoming distributions.
Questions in the middle?
- Will further portfolio sales match the strong returns of this early exit?
- How will currency fluctuations continue to impact CD3’s net asset value and distributions?
- What is the outlook for remaining investments in the vintage 2017 portfolio?
